Identification of Src’s role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches

Niamh McCabe; Leanne Stevenson; Enya Scanlon; Oliver Keminer; Richard Kennedy; Bjoern Windshuegel; Jaine Blayney; Richard Turkington

Identification of Src’s role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches

Niamh McCabe, Leanne Stevenson, Enya Scanlon, Oliver Keminer, Richard Kennedy, Bjoern Windshuegel, Jaine Blayney, Richard Turkington

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Publication status	Early online date - 22 Jun 2020
Event	IARC/EACR Early Career Researcher Symposium and Workshop 2020 - Galway, Ireland Duration: 26 Feb 2020 → 26 Feb 2021

Conference

Conference	IARC/EACR Early Career Researcher Symposium and Workshop 2020
Country	Ireland
City	Galway
Period	26/02/2020 → 26/02/2021

ASJC Scopus subject areas

Oncology

1 Active

R6547CNR: Training in Cancer Mechanisms and Therapeutics
Turkington, R. & Blayney, J.
29/09/2016 → …
Project: Research

Cite this

McCabe, N., Stevenson, L., Scanlon, E., Keminer, O., Kennedy, R., Windshuegel, B., Blayney, J., & Turkington, R. (2020). Identification of Src’s role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches. Abstract from IARC/EACR Early Career Researcher Symposium and Workshop 2020, Galway, Ireland.

McCabe, Niamh ; Stevenson, Leanne ; Scanlon, Enya ; Keminer, Oliver ; Kennedy, Richard ; Windshuegel, Bjoern ; Blayney, Jaine ; Turkington, Richard. / Identification of Src’s role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches. Abstract from IARC/EACR Early Career Researcher Symposium and Workshop 2020, Galway, Ireland.

@conference{bf42dc0c921144d3b672140f44c0d8d4,

title = "Identification of Src{\textquoteright}s role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches",

author = "Niamh McCabe and Leanne Stevenson and Enya Scanlon and Oliver Keminer and Richard Kennedy and Bjoern Windshuegel and Jaine Blayney and Richard Turkington",

year = "2020",

month = jun,

day = "22",

language = "English",

note = " IARC/EACR Early Career Researcher Symposium and Workshop 2020 ; Conference date: 26-02-2020 Through 26-02-2021",

}

McCabe, N, Stevenson, L , Scanlon, E, Keminer, O, Kennedy, R, Windshuegel, B, Blayney, J & Turkington, R 2020, 'Identification of Src’s role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches', IARC/EACR Early Career Researcher Symposium and Workshop 2020, Galway, Ireland, 26/02/2020 - 26/02/2021.

Identification of Src’s role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches. / McCabe, Niamh; Stevenson, Leanne ; Scanlon, Enya; Keminer, Oliver; Kennedy, Richard; Windshuegel, Bjoern; Blayney, Jaine ; Turkington, Richard.

2020. Abstract from IARC/EACR Early Career Researcher Symposium and Workshop 2020, Galway, Ireland.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - Identification of Src’s role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches

AU - McCabe, Niamh

AU - Stevenson, Leanne

AU - Scanlon, Enya

AU - Keminer, Oliver

AU - Kennedy, Richard

AU - Windshuegel, Bjoern

AU - Blayney, Jaine

AU - Turkington, Richard

PY - 2020/6/22

Y1 - 2020/6/22

M3 - Abstract

T2 - IARC/EACR Early Career Researcher Symposium and Workshop 2020

Y2 - 26 February 2020 through 26 February 2021

ER -

Identification of Src’s role in governing chemotherapy resistance in oesophageal adenocarcinoma through functional genomic and high-throughput drug screening approaches

Conference

ASJC Scopus subject areas

R6547CNR: Training in Cancer Mechanisms and Therapeutics

Cite this